NOBILI, Bruno
 Distribuzione geografica
Continente #
EU - Europa 7.097
NA - Nord America 4.605
AS - Asia 2.992
SA - Sud America 420
Continente sconosciuto - Info sul continente non disponibili 201
AF - Africa 26
OC - Oceania 2
Totale 15.343
Nazione #
US - Stati Uniti d'America 4.526
RU - Federazione Russa 4.316
SG - Singapore 1.066
CN - Cina 799
IE - Irlanda 787
UA - Ucraina 466
HK - Hong Kong 416
GB - Regno Unito 377
BR - Brasile 360
IT - Italia 353
DE - Germania 285
VN - Vietnam 268
SE - Svezia 155
FI - Finlandia 124
IN - India 122
TR - Turchia 103
FR - Francia 85
GR - Grecia 69
KR - Corea 60
JP - Giappone 58
CA - Canada 44
AR - Argentina 24
BE - Belgio 20
BD - Bangladesh 18
PL - Polonia 16
MX - Messico 15
IQ - Iraq 10
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
EC - Ecuador 8
NL - Olanda 8
PH - Filippine 8
ZA - Sudafrica 8
CO - Colombia 7
ES - Italia 7
IR - Iran 7
PY - Paraguay 7
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
AT - Austria 4
CL - Cile 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ID - Indonesia 4
KZ - Kazakistan 4
PK - Pakistan 4
PT - Portogallo 4
TN - Tunisia 4
DZ - Algeria 3
GE - Georgia 3
MY - Malesia 3
AU - Australia 2
AZ - Azerbaigian 2
EG - Egitto 2
IS - Islanda 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
MA - Marocco 2
MD - Moldavia 2
MQ - Martinica 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
LT - Lituania 1
LV - Lettonia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 15.148
Città #
Moscow 1.535
Dublin 786
Jacksonville 694
Chandler 596
Hong Kong 408
Singapore 407
San Jose 400
Santa Clara 396
Ashburn 226
Council Bluffs 167
Ann Arbor 125
Princeton 120
Medford 111
Boardman 104
Bengaluru 103
Beijing 98
Hefei 98
San Mateo 87
Ho Chi Minh City 79
Wilmington 78
Dallas 73
Hanoi 71
Caserta 69
Woodbridge 69
Nanjing 62
Seoul 59
Bremen 48
New York 39
Los Angeles 35
Munich 31
Cambridge 30
Roxbury 29
São Paulo 27
The Dalles 27
Dearborn 21
Düsseldorf 21
Istanbul 21
Kunming 21
Naples 21
Brussels 20
Jinan 19
Da Nang 16
Guangzhou 16
Mountain View 16
Des Moines 15
Napoli 15
Warsaw 15
Chicago 14
Frankfurt am Main 14
Grumo Nevano 13
Haiphong 13
Nanchang 13
Auburn Hills 12
Belo Horizonte 12
Curitiba 12
Norwalk 12
Tianjin 12
Atlanta 11
Orem 11
Rio de Janeiro 11
Zhengzhou 11
Elora 9
Hangzhou 9
Boston 8
Houston 8
Milan 8
Shenyang 8
Brno 7
Brooklyn 7
Hebei 7
Helsinki 7
Hillsboro 7
London 7
Montreal 7
Nha Trang 7
Toronto 7
Memphis 6
Ningbo 6
Redwood City 6
Riyadh 6
Rome 6
San Francisco 6
Seattle 6
Shanghai 6
Tashkent 6
Bắc Ninh 5
Johannesburg 5
Lanzhou 5
Newark 5
Nocera Inferiore 5
Porto Alegre 5
Tokyo 5
Verona 5
Amsterdam 4
Asunción 4
Baghdad 4
Brasília 4
Campinas 4
Caracas 4
Centrale 4
Totale 7.930
Nome #
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis 256
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 211
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation. 209
Cannabinoid receptor 2 Q63R variant could modulate the relationship between childhood obesity and age at menarche 201
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 194
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. 191
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 190
Iron overload enhances human mesenchymal stromal cell growth and hampers matrix calcification 189
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. 187
A case of cutaneous mastocytosis associated with A-G dysgammaglobulinemia 186
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 176
[Sanfilippo's disease of type B. Study of the enzymatic deficiency in a family] 171
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity 165
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. 163
Vitamin A and infancy. Biochemical, functional, and clinical aspects 162
Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties. 161
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. 161
Ematologia 160
Vitamin A and infancy. Biochemical, functional, and clinical aspects 159
[Fluorimetric determination of erythrocytic free protoporphyrins in evaluation of iron deficiency states] 157
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. 156
A modification of the 'pink test' may improve the diagnosis of hereditary spherocytosis 156
The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function 154
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. 154
ERITROCITOSI CONGENITA CAUSATA DA ALTERAZIONI DEL SISTEMA SENSORE DELL’OSSIGENO 153
Concordanza tra visita oculistica e RM encefalo nello screening del glioma delle vie ottiche nei pazienti pediatrici con neurofibromatosi tipo 1 151
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. 148
CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity 147
[Antibiotic therapy: cephalosporins] 147
Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant 146
[Hematological screening of a group of children from a school population] 146
[Current possibilities of the use of ferritin in clinical diagnosis] 145
The 17-estradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression 144
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 143
[Diagnostic methods in iron deficiency states. Comparative data on free protoporphyrins of erythrocytes in iron deficiency states and in thalassemia] 143
[Glycerol test in thalassemia diagnosis (author's transl)] 143
[Alpha thalassemia in Campania: results of a survey of 319 newborn infants] 141
[Prevention therapy of infections in the course of granulocytopenia] 141
Infant hypervitaminosis A causes severe anemia and thrombocytopenia: evidence of a retinol-dependent bone marrow cell growth inhibition 140
[The L-dopa test in diagnosis of pituitary dwarfism] 140
[A case of progeria associated with Uhl's syndrome] 140
[Comparative evaluation of the activity "in vitro" of 4 aminoglycosides (gentamycin, sisomicin, tobramycin, amikacin)] 139
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy 139
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. 138
Effects of nebivolol on human platelet aggregation 138
Interaction between metabotropic and NMDA glutamate receptors participate in the periaqueductal grey pain modulatory system 136
[An unusual salt-losing syndrome: pseudohypoaldosteronism. Description of a case] 135
Amoxicillin-induced hemolytic anemia in a child with glucose 6-phosphate isomerase deficiency 135
Apparently normal ankyrin content in unsplenectomized hereditary spherocytosis patients with the inactivation of one ankyrin (ANK1) allele 132
[Problems of antibiotic therapy in pediatrics] 132
Frequent de novo monoallelic expression of beta-spectrin gene (SPTB) in children with hereditary spherocytosis and isolated spectrin deficiency 131
Studio retrospettivo sulle complicanze emato-oncologiche nella neurofibromatosi tipo 1 in età pediatrica 131
The DMT1 IVS4+44C>A polymorphism and the risk of iron deficiency anemia in children with celiac disease 131
Diamond-Blackfan anemia: expansion of erythroid progenitors in vitro by IL-9, but exclusion of a significant pathogenetic role for the IL-9 gene and the hematopoietic gene cluster on chromosome 5q 130
[Very unusual combination: congenital nephrosis and bilateral congenital glaucoma] 130
Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis 129
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption 128
[Fetal hemoglobin during the first year of life: evaluation of total erythrocytes, neocytes and gerocytes] 126
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study 125
[Cartilage-hair hypoplasia: clinical and immunological study] 125
[Prenatal diagnosis: current knowledge and future prospects] 125
Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience 123
Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura 122
Hereditary spherocytosis due to a novel frameshift mutation in AE1 cytoplasmic COOH terminal tail: band 3 Vesuvio 119
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 119
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 116
Reversible erythrocyte skeleton destabilization is modulated by beta-spectrin phosphorylation in childhood leukemia 113
L1 effects on reactive oxygen (ROS) and nitrogen species (RNS) release, hemoglobin oxidation, low molecular weight antioxidants, and antioxidant enzyme activities in red and white blood cells of thalassemic patients 113
Diamond-Blackfan anaemia in the Italian population 112
La prevenzione dell’anemia mediterranea in Campania: stato attuale e prospettive 112
Esame emocromocitometrico 112
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. 111
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children 111
ROBO2 gene variants are associated with familial vesicoureteral reflux 110
Spectrin/band 3 ratio as diagnostic tool in hereditary spherocytosis 110
COINHERITANCE OF GILBERT SYNDROME INCREASES THE RISK FOR DEVELOPING GALLSTONES IN PATIENTS WITH HEREDITARY SPHEROCYTOSIS 110
Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis 110
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation 109
Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines:assessment of Italian experience 108
Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation 108
Le anemie diseritropoietiche 108
REPORT OF ADVERSE TRANSFUSION REACTIONS: EMOCOMPONENTS VIA APHERESIS VS WHOLE BLOOD INPEDIATRIC PATIENTS 108
Clinical and biochemical study of thalassemia intermedia in Campania (southern Italy) 107
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response 106
Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis 106
Clinical and molecular evaluation of non-dominant hereditary spherocytosis 106
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 106
Erythropoietin treatment can prevent blood transfusion in infantile pyknocytosis 105
Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II) 105
Flow-cytometric analysis of erythrocytes and reticulocytes in congenital dyserythropoietic anaemia type II (CDA II): value in differential diagnosis with hereditary spherocytosis 105
Molecular heterogeneity of hereditary elliptocytosis in Italy 105
Bart's hemoglobin in newborn infants of Campania 104
Serum Hepcidin and Iron Absorption in Pediatric Inflammatory Bowel Disease. 104
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group 103
Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia 103
ROBO2 gene variants are associated with familial vesicouretral reflux 103
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus 103
EVALUATION OF BODY IRON STATUS IN ITALIAN CARRIERS OF BETA-THALASSEMIA TRAIT 102
Terapia con rHu Epo in un caso di diabete mellito “early onset” ed anemia aplastica normocitica 102
Splenectomy in children with chronic ITP: long-term efficacy and relation between its outcome and responses to previous treatments 101
Totale 13.602
Categoria #
all - tutte 51.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022659 0 0 7 18 257 7 13 19 27 72 66 173
2022/20231.814 144 40 27 205 206 176 3 134 804 13 33 29
2023/2024537 69 14 22 65 196 29 15 25 4 0 29 69
2024/20251.649 9 18 19 71 288 154 274 160 241 224 108 83
2025/20267.075 256 322 340 300 587 4.075 405 244 234 132 138 42
2026/2027586 44 178 364 0 0 0 0 0 0 0 0 0
Totale 15.343